top of page

Full List of Qualifying Conditions

Amyotrophic Lateral Sclerosis (Effective 2016)*

Cachexia (Effective 2012)

Cancer (Effective 2012)

Cerebral Palsy (Effective 2016)

Complex Regional Pain Syndrome, Type 1 and Type II (Effective 2016)*

Chronic Neuropathic Pain Associated with Degenerative Spinal Disorders (Effective 2018)*

Chronic Pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention (Effective 2020)*

Crohn's Disease (Effective 2012)

Cystic Fibrosis (Effective 2016)

Damage to the Nervous Tissue of the Spinal Cord with Objective Neurological Indication of Intractable Spasticity (Effective 2012)

Ehlers-Danlos Syndrome Associated with Chronic Pain (Effective 2020)*

Epilepsy (Effective 2012)

Glaucoma (Effective 2012)

Hydrocephalus with Intractable Headache (Effective 2018)*

Interstitial Cystitis (Effective 2019)*

Intractable Headache Syndromes (Effective 2018)*

Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)*

Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity (Effective 2016)

MALS Syndrome (Median Arcuate Ligament Syndrome) (Effective 2019)*

Multiple Sclerosis (Effective 2012)

Muscular Dystrophy (Effective 2018)*

 

​Neuropathic Facial Pain (Effective 2018)*

Osteogenesis Imperfecta (Effective 2018)*

Parkinson's Disease (Effective 2012)

Positive Status for Human Immunodeficiency Virus or Acquired Immune Deficiency Syndrome (Effective 2012)

Post Herpetic Neuralgia (Effective 2018)*

Post Laminectomy Syndrome with Chronic Radiculopathy (Effective 2016)*

Post Traumatic Stress Disorder (Effective 2012)

Severe Psoriasis and Psoriatic Arthritis (Effective 2016)*

Severe Rheumatoid Arthritis (Effective 2018)*

Sickle Cell Disease (Effective 2016)*

Spasticity or Neuropathic Pain Associated with Fibromyalgia (Effective 2018)*

Terminal Illness Requiring End-Of-Life Care (Effective 2016)

Tourette Syndrome (Effective 2019)*

Ulcerative Colitis (Effective 2016)*

Uncontrolled Intractable Seizure Disorder (Effective 2016)

Vulvodynia and Vulvar Burning (Effective 2019)*

Wasting Syndrome (Effective 2012)

 

bottom of page